By supporting cellular proliferation, survival, and therapy resistance, PON2 acts as a critical regulator of cancer cell fitness, effects that are markedly diminished upon PON2 knockdown [71,101,102,103,104,105,106]. The gene discussed is PON2; the disease is cancer.